Free Trial
NASDAQ:NURO

NeuroMetrix Q3 2024 Earnings Report

NeuroMetrix logo
$4.55 +0.19 (+4.36%)
Closing price 05/1/2025 07:55 PM Eastern
Extended Trading
$4.55 0.00 (0.00%)
As of 05/1/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroMetrix EPS Results

Actual EPS
-$0.75
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
-$1.66

NeuroMetrix Revenue Results

Actual Revenue
$0.59 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeuroMetrix Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Conference Call Date
Tuesday, November 5, 2024
Conference Call Time
11:30AM ET

Upcoming Earnings

NeuroMetrix's next earnings date is estimated for Wednesday, May 21, 2025, based on past reporting schedules.

NeuroMetrix Earnings Headlines

NeuroMetrix finalizes acquisition by electroCore
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
See More NeuroMetrix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeuroMetrix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeuroMetrix and other key companies, straight to your email.

About NeuroMetrix

NeuroMetrix (NASDAQ:NURO), a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

View NeuroMetrix Profile

More Earnings Resources from MarketBeat